Listed

Collegium Pharmaceutical, Inc: Form 10-Q for the period ended Mar 31, 2017

Filed with the SEC on May 10, 2017 and accepted by EDGAR at May 10, 2017, 16:06 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2017-01-01 to 2017-03-31$2.1mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2017-01-01 to 2017-03-31$22.8mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-01-01 to 2017-03-31−$23.2mus-gaap:OperatingIncomeLoss
Net income3 months2017-01-01 to 2017-03-31−$23.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-01-01 to 2017-03-31−$0.79us-gaap:EarningsPerShareBasicAndDiluted
Basic EPS3 months2017-01-01 to 2017-03-31−$0.79us-gaap:EarningsPerShareBasic
Capital expenditure3 months2017-01-01 to 2017-03-31$29.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-03-31$129.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-03-31$136.5mus-gaap:AssetsCurrent
Total assetsAt period end2017-03-31$139.8mus-gaap:Assets
Current liabilitiesAt period end2017-03-31$24.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-03-31$25.5mus-gaap:Liabilities
Shareholders' equityAt period end2017-03-31$114.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-17-004119. Last ingested by Listed: Nov 10, 2026, 23:07 ET. Listed shows no prices and gives no investment advice.